Using Live, Attenuated Influenza Vaccine for Prevention and Control of Influenza; Supplemental Recommendations of the Advisory Committee on Immunization Practices (ACIP)

Bridges, Carolyn B.; Cox, Nancy (Nancy J.); Fukuda, Keiji; Harper, Scott A.

CDC STACKS serves as an archival repository of CDC-published products including scientific findings, journal articles, guidelines, recommendations, or other public health information authored or co-authored by CDC or funded partners. As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.

Superseded

This Document Has Been Replaced By: Prevention and Control of Seasonal Influenza with Vaccines : Recommendations of the Advisory Committee on Immunization Practices — United States, 2017–18 Influenza Season

Using Live, Attenuated Influenza Vaccine for Prevention and Control of Influenza; Supplemental Recommendations of the Advisory Committee on Immunization Practices (ACIP)

September 26, 2003
By Bridges, Carolyn B. ; Cox, Nancy (Nancy J.) ; Fukuda, Keiji ; ...
Source: Morbidity and Mortality Weekly Report (MMWR): Recommendations and Reports, 2003; v. 52, no. 13
Series: Recommendations and Reports: Morbidity and Mortality Weekly Report (MMWR)

[PDF-256.79 KB]

English

Details You May Also Like

Details:

Journal Article:

Morbidity and Mortality Weekly Report (MMWR): Recommendations and Reports
Personal Author:

Bridges, Carolyn B. ; Cox, Nancy (Nancy J.) ; Fukuda, Keiji ; Harper, Scott A.

Bridges, Carolyn B. ; Cox, Nancy (Nancy J.) ; Fukuda, Keiji ; Harper, Scott A. Less -
Corporate Authors:

United States. Advisory Committee on Immunization Practices. ; National Center for Infectious Diseases (U.S.). Division of Viral and Rickettsial Diseases. ; National Immunization Program (Centers for Disease Control and Prevention), Epidemiology and Surveillance Division.

United States. Advisory Committee on Immunization Practices. ; National Center for Infectious Diseases (U.S.). Division of Viral and Rickettsial Diseases. ; National Immunization Program (Centers for Disease Control and Prevention), Epidemiology and Surveillance Division. Less -
Description:

This report summarizes recommendations by the Advisory Committee on Immunization Practices (ACIP) for using intranasally administered, trivalent, cold-adapted, live, attenuated influenza vaccine (LAIV), which was approved for use in the United States on June 17, 2003 (FluMist trade mark, produced by MedImmune, Inc., Gaithersburg, Maryland). LAIV is currently approved for use among healthy persons (i.e., those not at high risk for complications from influenza infection) aged 5-49 years. This report includes information regarding 1) vaccine composition and mechanisms of action; 2) comparison between LAIV and trivalent inactivated influenza vaccine; 3) effectiveness and safety of LAIV; 4) transmission and stability of LAIV viruses; 5) recommendations and contraindications for using LAIV; and 6) dosage and administration of LAIV. This report supplements the 2003 ACIP recommendations regarding prevention and control of influenza (CDC. Prevention and Control of Influenza: Recommendations of the Advisory Committee on Immunization Practices [ACIP]. MMWR 2003;52[No. RR-8]:1-36.)
Content Notes:

Includes bibliographical references and index (p. 7-8).
Subjects:

[+]

Influenza, Human / Prevention & Control Influenza Vaccines / Administration & Dosage Influenza Vaccines / Adverse Effects Influenza Vaccines / Contraindications Vaccination / Standards Vaccines, Attenuated
Source:

Morbidity and Mortality Weekly Report (MMWR): Recommendations and Reports, 2003; v. 52, no. 13
Series:

Recommendations and Reports: Morbidity and Mortality Weekly Report (MMWR)
ISSN:

1057-5987 (print);1545-8601 (digital);
Pubmed ID:

14557799
Document Type:

Journal Issue
Genre:

Practice Guideline
Pages in Document:

12 pdf pages
Volume:

52
Issue:

13
Collection(s):

Advisory Committee on Immunization Practices (ACIP) Guidelines and Recommendations Morbidity and Mortality Weekly Report (MMWR)
Main Document Checksum:

[+]

urn:sha-512:404bf771e8ca1a6ec7e63ba5e551ff22e66a39ab593ee185b9d18b92ac5df28b9670acbf69346b0acbd39fbe94e44f5e20ea7a95e24d990b6c00e9fb8b4eda76
Download URL:

https://stacks.cdc.gov/view/cdc/13510/cdc_13510_DS1.pdf
File Type:

No Additional Files

More +

Superseded

Using Live, Attenuated Influenza Vaccine for Prevention and Control of Influenza; Supplemental Recommendations of the Advisory Committee on Immunization Practices (ACIP)

Details:

Supporting Files

You May Also Like